Phase II study of neoadjuvant androgen deprivation followed by external-beam radiotherapy with 9 months of androgen deprivation for intermediate- to high-risk localized prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Androgen Antagonists
  • Neoadjuvant Therapy
  • Prostatic Neoplasms
  • Radiotherapy

abstract

  • The combination of 9 months of AD and RT, with initiation of RT individualized on the basis of maximum response to AD, achieves disease control rates comparable with past studies, while preserving potency in many patients. Further studies are warranted to determine the optimal combination of AD and RT in this patient population.

publication date

  • January 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2005.05.0419

PubMed ID

  • 17194907

Additional Document Info

start page

  • 77

end page

  • 84

volume

  • 25

number

  • 1